ATE488495T1 - Antihypercholesterinämische verbindungen - Google Patents

Antihypercholesterinämische verbindungen

Info

Publication number
ATE488495T1
ATE488495T1 AT06816084T AT06816084T ATE488495T1 AT E488495 T1 ATE488495 T1 AT E488495T1 AT 06816084 T AT06816084 T AT 06816084T AT 06816084 T AT06816084 T AT 06816084T AT E488495 T1 ATE488495 T1 AT E488495T1
Authority
AT
Austria
Prior art keywords
antihypercholesterolemic compounds
antihypercholesterolemic
compounds
Prior art date
Application number
AT06816084T
Other languages
English (en)
Inventor
Robert Devita
Gregori Morriello
Peter Lin
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE488495T1 publication Critical patent/ATE488495T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06816084T 2005-10-05 2006-09-29 Antihypercholesterinämische verbindungen ATE488495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72378105P 2005-10-05 2005-10-05
PCT/US2006/038551 WO2007044318A2 (en) 2005-10-05 2006-09-29 Anti-hypercholesterolemic compounds

Publications (1)

Publication Number Publication Date
ATE488495T1 true ATE488495T1 (de) 2010-12-15

Family

ID=37845278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06816084T ATE488495T1 (de) 2005-10-05 2006-09-29 Antihypercholesterinämische verbindungen

Country Status (25)

Country Link
US (2) US20090137546A1 (de)
EP (1) EP1934175B1 (de)
JP (1) JP4879991B2 (de)
KR (1) KR20080050610A (de)
CN (1) CN101277930A (de)
AR (1) AR058068A1 (de)
AT (1) ATE488495T1 (de)
AU (1) AU2006302584B2 (de)
BR (1) BRPI0616834A2 (de)
CA (1) CA2624481C (de)
CR (1) CR9903A (de)
DE (1) DE602006018341D1 (de)
DO (1) DOP2006000211A (de)
EA (1) EA200801008A1 (de)
ES (1) ES2354460T3 (de)
GT (1) GT200600444A (de)
IL (1) IL190434A0 (de)
MA (1) MA30006B1 (de)
NO (1) NO20082075L (de)
PE (1) PE20070493A1 (de)
SV (1) SV2009002863A (de)
TN (1) TNSN08153A1 (de)
TW (1) TW200806623A (de)
WO (1) WO2007044318A2 (de)
ZA (1) ZA200802587B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176193B2 (en) * 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
GB0215579D0 (en) * 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
JP2007516287A (ja) * 2003-12-23 2007-06-21 メルク　エンド　カムパニー　インコーポレーテッド 抗高コレステロール血症化合物
GB0329778D0 (en) * 2003-12-23 2004-01-28 Astrazeneca Ab Chemical compounds
ATE485267T1 (de) * 2003-12-23 2010-11-15 Astrazeneca Ab Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
UY29607A1 (es) * 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
AR057072A1 (es) * 2005-06-22 2007-11-14 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
SA06270191B1 (ar) * 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AR057383A1 (es) * 2005-06-22 2007-12-05 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
AR057380A1 (es) * 2005-06-22 2007-11-28 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
AR054482A1 (es) * 2005-06-22 2007-06-27 Astrazeneca Ab Derivados de azetidinona para el tratamiento de hiperlipidemias
TW200806623A (en) * 2005-10-05 2008-02-01 Merck & Co Inc Anti-hypercholesterolemic compounds
DE102005055726A1 (de) * 2005-11-23 2007-08-30 Sanofi-Aventis Deutschland Gmbh Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
AR060623A1 (es) * 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CA2672221A1 (en) * 2006-12-20 2008-07-17 Merck & Co., Inc. Anti-hypercholesterolemic compounds
DE102009023046B4 (de) 2008-05-30 2016-10-13 Hyundai Motor Company Automatisch schaltbares Getriebe eines Kraftfahrzeuges
WO2010056788A1 (en) * 2008-11-17 2010-05-20 Merck Sharp & Dohme Corp. Anti-hypercholesterolemic compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658441B2 (en) * 1991-07-23 1995-04-13 Schering Corporation Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
WO1995035277A1 (en) * 1994-06-20 1995-12-28 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
US5624920A (en) * 1994-11-18 1997-04-29 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
IL156550A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
US7176194B2 (en) * 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
US7176193B2 (en) * 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
WO2004081002A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
JP2005015434A (ja) * 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
JP2007516287A (ja) * 2003-12-23 2007-06-21 メルク　エンド　カムパニー　インコーポレーテッド 抗高コレステロール血症化合物
EP1851197A2 (de) * 2005-02-09 2007-11-07 Microbia, Inc. Phenylazetidinon-derivate
US7696177B2 (en) * 2005-06-15 2010-04-13 Merck Sharp & Dohme Corp. Anti-hypercholesterolemic compounds
TW200806623A (en) * 2005-10-05 2008-02-01 Merck & Co Inc Anti-hypercholesterolemic compounds
DE102005055726A1 (de) * 2005-11-23 2007-08-30 Sanofi-Aventis Deutschland Gmbh Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
KR20090091120A (ko) * 2006-11-02 2009-08-26 사노피-아벤티스 도이칠란트 게엠베하 향상된 약리학적 특성을 갖는 피페라진-1-설폰산으로 치환된 신규한 디페닐아제티디논

Also Published As

Publication number Publication date
AU2006302584B2 (en) 2011-10-13
KR20080050610A (ko) 2008-06-09
ES2354460T3 (es) 2011-03-15
US7704988B2 (en) 2010-04-27
JP2009511475A (ja) 2009-03-19
WO2007044318A2 (en) 2007-04-19
CR9903A (es) 2008-07-29
US20070078098A1 (en) 2007-04-05
SV2009002863A (es) 2009-02-19
CN101277930A (zh) 2008-10-01
US20090137546A1 (en) 2009-05-28
JP4879991B2 (ja) 2012-02-22
ZA200802587B (en) 2009-06-24
DE602006018341D1 (de) 2010-12-30
NO20082075L (no) 2008-07-04
GT200600444A (es) 2007-05-04
IL190434A0 (en) 2008-11-03
AR058068A1 (es) 2008-01-23
WO2007044318A3 (en) 2007-07-12
PE20070493A1 (es) 2007-06-13
EA200801008A1 (ru) 2009-02-27
TW200806623A (en) 2008-02-01
BRPI0616834A2 (pt) 2016-08-23
CA2624481C (en) 2012-04-03
CA2624481A1 (en) 2007-04-19
AU2006302584A1 (en) 2007-04-19
MA30006B1 (fr) 2008-12-01
EP1934175B1 (de) 2010-11-17
EP1934175A2 (de) 2008-06-25
TNSN08153A1 (en) 2009-10-30
DOP2006000211A (es) 2007-05-31

Similar Documents

Publication Publication Date Title
LTC2343304I2 (lt) Biocidiniai boronoftalido junginiai
CY2013047I2 (el) Ενωσεις διαρυλυδαντοϊνης
EP1874736A4 (de) Kondensierte heterocyclische verbindungen
ATE516293T1 (de) Antivirale verbindungen
ATE434618T1 (de) Spirozyklische verbindungen als hdac-hemmer
LT2495016T (lt) Bicikliniai heteroarilų junginiai
ATE546440T1 (de) Organische verbindungen
PT1879873E (pt) Compostos de azol neuroterapêuticos
BRPI0608999A2 (pt) conjunto de fixação
NL1031385A1 (nl) Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen.
EP1876179A4 (de) Thienopyrimidonverbindungen
ATE512953T1 (de) Heterocyclische verbindungen
DE602006000257D1 (de) Elektronenstrahlsterilisator
DE602006021542D1 (de) Resolver-anordnung
BRPI0607440A2 (pt) conjunto de fixação
DE502005004675D1 (de) Organisches Bauelement
DE602006018341D1 (de) Antihypercholesterinämische verbindungen
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
BRPI0619124A2 (pt) conjunto de fixação
ATE483700T1 (de) Chemische verbindungen
ITMI20042238A1 (it) Composti per fluoropolirterei
EP1871741A4 (de) Substituierte azetidinone
DE602005003882D1 (de) Asparaginsäureesterfunktionelle Verbindungen
EP1907393A4 (de) Introvertierte cucurbituril-verbindungen
DE502006001027D1 (de) Cyanuraten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties